Outset Medical Q4 revenue falls

Reuters

Yesterday

Outset Medical Q4 revenue falls

Overview

Medical technology firm's Q4 revenue fell 2% yr/yr
Gross margin for Q4 expanded nearly 600 basis points

Outlook

Outset Medical projects 2026 revenue between $125 mln and $130 mln
Company expects non-GAAP gross margin in low to mid-40% range for 2026
Outset Medical plans to launch next-gen Tablo platform in Q2 2026

Result Drivers

GROSS MARGIN EXPANSION - Gross margin improved by nearly 600 basis points in Q4 due to cost management and operational efficiencies
RECURRING REVENUE GROWTH - Recurring revenue from Tablo consumables and services grew 6% in 2025

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q4 Net Income		-$19.49 mln
Q4 Gross Margin		42.40%
Q4 Basic EPS		-$1.09
Q4 Gross Profit		$12.23 mln
Q4 Operating Expenses		$29.86 mln

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Outset Medical Inc is $11.50, about 144.7% above its February 10 closing price of $4.70

Press Release: ID:nGNX9W75vK

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2610569966"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2610569966\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2610569966?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-12 05:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610569966","market":"fut","top_or_hot":-1,"title":"Outset Medical Q4 revenue falls","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Outset Medical Q4 revenue falls</title></head><body><p><span>Overview</span></p><ul><li><p>Medical technology firm's Q4 revenue fell 2% yr/yr</p></li><li><p>Gross margin for Q4 expanded nearly 600 basis points</p></li></ul><p><span>Outlook</span></p><ul><li><p>Outset Medical projects 2026 revenue between $125 mln and $130 mln</p></li><li><p>Company expects non-GAAP gross margin in low to mid-40% range for 2026</p></li><li><p>Outset Medical plans to launch next-gen Tablo platform in <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2026</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>GROSS MARGIN EXPANSION - Gross margin improved by nearly 600 basis points in Q4 due to cost management and operational efficiencies</p></li><li><p>RECURRING REVENUE GROWTH - Recurring revenue from Tablo consumables and services grew 6% in 2025</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Net Income</p></td><td></td><td><p>-$19.49 mln</p></td><td></td></tr><tr><td><p>Q4 Gross Margin</p></td><td></td><td><p>42.40%</p></td><td></td></tr><tr><td><p>Q4 Basic EPS</p></td><td></td><td><p>-$1.09</p></td><td></td></tr><tr><td><p>Q4 Gross Profit</p></td><td></td><td><p>$12.23 mln</p></td><td></td></tr><tr><td><p>Q4 Operating Expenses</p></td><td></td><td><p>$29.86 mln</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 3 \"strong buy\" or \"buy\", 2 \"hold\" and no \"sell\" or \"strong sell\"</p></li><li><p>The average consensus recommendation for the advanced medical equipment &amp; technology peer group is \"buy\"</p></li><li><p>Wall Street's median 12-month price target for Outset Medical Inc is $11.50, about 144.7% above its February 10 closing price of $4.70</p></li></ul><p>Press Release: <span>ID:nGNX9W75vK</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Outset Medical Q4 revenue falls</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOutset Medical Q4 revenue falls\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-12 05:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Outset Medical Q4 revenue falls</title></head><body><p><span>Overview</span></p><ul><li><p>Medical technology firm's Q4 revenue fell 2% yr/yr</p></li><li><p>Gross margin for Q4 expanded nearly 600 basis points</p></li></ul><p><span>Outlook</span></p><ul><li><p>Outset Medical projects 2026 revenue between $125 mln and $130 mln</p></li><li><p>Company expects non-GAAP gross margin in low to mid-40% range for 2026</p></li><li><p>Outset Medical plans to launch next-gen Tablo platform in <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2026</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>GROSS MARGIN EXPANSION - Gross margin improved by nearly 600 basis points in Q4 due to cost management and operational efficiencies</p></li><li><p>RECURRING REVENUE GROWTH - Recurring revenue from Tablo consumables and services grew 6% in 2025</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Net Income</p></td><td></td><td><p>-$19.49 mln</p></td><td></td></tr><tr><td><p>Q4 Gross Margin</p></td><td></td><td><p>42.40%</p></td><td></td></tr><tr><td><p>Q4 Basic EPS</p></td><td></td><td><p>-$1.09</p></td><td></td></tr><tr><td><p>Q4 Gross Profit</p></td><td></td><td><p>$12.23 mln</p></td><td></td></tr><tr><td><p>Q4 Operating Expenses</p></td><td></td><td><p>$29.86 mln</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 3 \"strong buy\" or \"buy\", 2 \"hold\" and no \"sell\" or \"strong sell\"</p></li><li><p>The average consensus recommendation for the advanced medical equipment &amp; technology peer group is \"buy\"</p></li><li><p>Wall Street's median 12-month price target for Outset Medical Inc is $11.50, about 144.7% above its February 10 closing price of $4.70</p></li></ul><p>Press Release: <span>ID:nGNX9W75vK</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OM","symbol_name":"Outset Medical Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nL1N3Z71BE:1","article_id":"2610569966","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2610569966","pubTimestamp":1770844179,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Outset Medical Q4 revenue fallsOverviewMedical technology firm's Q4 revenue fell 2% yr/yrGross margin for Q4 expanded nearly 600 basis pointsOutlookOutset Medical projects 2026 revenue between $125 ml","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OM":"Outset Medical Inc.","BK4082":"医疗保健设备"},"translate_title":"Outset Medical第四季度收入下降","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OM":0.9},"content_text":"Outset Medical Q4 revenue fallsOverviewMedical technology firm's Q4 revenue fell 2% yr/yrGross margin for Q4 expanded nearly 600 basis pointsOutlookOutset Medical projects 2026 revenue between $125 mln and $130 mlnCompany expects non-GAAP gross margin in low to mid-40% range for 2026Outset Medical plans to launch next-gen Tablo platform in Q2 2026Result DriversGROSS MARGIN EXPANSION - Gross margin improved by nearly 600 basis points in Q4 due to cost management and operational efficienciesRECURRING REVENUE GROWTH - Recurring revenue from Tablo consumables and services grew 6% in 2025Key DetailsMetricBeat/MissActualConsensus EstimateQ4 Net Income-$19.49 mlnQ4 Gross Margin42.40%Q4 Basic EPS-$1.09Q4 Gross Profit$12.23 mlnQ4 Operating Expenses$29.86 mlnAnalyst CoverageThe current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 3 \"strong buy\" or \"buy\", 2 \"hold\" and no \"sell\" or \"strong sell\"The average consensus recommendation for the advanced medical equipment & technology peer group is \"buy\"Wall Street's median 12-month price target for Outset Medical Inc is $11.50, about 144.7% above its February 10 closing price of $4.70Press Release: ID:nGNX9W75vKFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}